Ritvij Bowry, MD
Neurocritical Care · Houston, TXNPI 1912131053
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. AstraZeneca accounts for 61.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $8,287 and has fallen 99.6% since, to $33 in 2025. Among neurocritical care clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $380.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$7K
- Portola Pharmaceuticals, LLC$3K
- Astrazeneca UK Limited$1K
- Imperative Care, Inc$154
- Edwards Lifesciences$42
- BD$33
- plus $29 from 2 others
Across 5 payments — averaging $31,595 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$128K
- Boehringer Ingelheim$30K
What the payments were for
- Consulting fees$5,74550%
- Speaking & faculty fees$2,08318%
- Travel & lodging$2,48422%
- Food & beverage$1,11810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $6,987 |
| Portola Pharmaceuticals, LLC | 9 | $2,717 |
| Astrazeneca UK Limited | 10 | $1,468 |
| Imperative Care, Inc | 1 | $154 |
| Edwards Lifesciences | 1 | $42 |
| BD | 1 | $33 |
| Boston Scientific | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$10,560
- ZOOM RDL RADIAL ACCESS SYSTEM, 103CM$154
How this compares
$11,430 in reported general payments places this provider in the 90th percentile of 46 neurocritical care providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurocritical care in Houston
- Ashutosh MahapatraHouston$27K
- Huimahn ChoiHouston$2K
- Muhammad Ubaid HafeezHouston$2K
- Tiffany ChangHouston$816
- Abhay KumarHouston$723
- Aaron GusdonHouston$661
- Luis TorresHouston$449
- Swathi KondapalliHouston$389
- Robert BrownHouston$222
- Eman AlnosairHouston$207
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.